Abstract：Objective To investigate the willingness to get herpes zoster (HZ) vaccines and its affecting factors among people aged ≥ 50 years in Luohu District of Shenzhen City. Methods From November 2021 to January 2022, a stratified random sampling method was used to recruit participants from the grassroots medical institutions, and a questionnaire survey was conducted. SPSS 27.0 software was employed to perform χ2 test and logistic regression analysis, and the factors affecting vaccination willingness were identified. Results Among 537 subjects surveyed, 86.03% of the subjects were willing to get HZ vaccine. Logistic regression analysis showed that subjects who knew the susceptibleage forHZ (OR=1.259, 95%CI:1.010-1.571), who had worried that they or their relatives and friends were suffering from HZ (OR=2.975, 95%CI:1.607-5.506), who obtained the vaccine information through the Internet (OR=2.408, 95%CI:1.289-4.496) and the introduction of medical staff (OR=1.999, 95%CI:1.102-3.625) and who were concerned about the safety of the vaccine (OR=2.827, 95%CI:1.374-5.814) were more willing to receive HZ vaccine. The subjects who did not accept (OR=0.136, 95%CI:0.056-0.332) or were uncertain whether they could accept (OR=0.274, 95%CI:0.141-0.533) mild adverse reactions after vaccination had lower vaccination willingness than those who could accept them. Conclusion The willingness to receive HZ vaccine among people aged ≥ 50 years in Luohu District have been improved compared with previous research results in other districts. Vaccination willingness can be furtherimproved through the scientific propaganda about herpes zoster and HZ vaccine and the correct guidance of medical staff.
王希丹, 黄凯, 陈传德, 杨洁. 深圳市罗湖区≥50岁人群带状疱疹疫苗接种意愿及影响因素分析[J]. 实用预防医学, 2023, 30(11): 1290-1295.
WANG Xidan, HUANG Kai, CHEN Chuande, YANG Jie. Willingness to receive herpes zoster vaccines and its influencing factors among people aged ≥50 years in Luohu District of Shenzhen City. , 2023, 30(11): 1290-1295.
[1] 中国医师协会皮肤科医师分会带状疱疹专家共识工作组. 带状疱疹中国专家共识[J]. 中华皮肤科杂志,2018,51(6): 403-408. [2] 带状疱疹后神经痛诊疗共识编写专家组. 带状疱疹后神经痛诊疗中国专家共识[J]. 中国疼痛医学杂志,2016,22(3): 161-167. [3] Zhu Q, Zheng H, Qu H, et al. Epidemiology of herpes zoster among adults aged 50 and above in Guangdong, China[J]. Hum Vacc Immunother,2015,11(8):2113-2118. [4] 徐文体,王奇凡. 带状疱疹及带状疱疹后神经痛流行病学及经济负担研究进展[J]. 天津医药,2018,46(5):552-555. [5] Lin YH,Huang LM,Chang IS,et al. Disease burden and epidemiology of herpes zoster in pre-vaccine Taiwan [J]. Vaccine,2010,28(5):1217-1220. [6] Werner RN, Nikkels AF, Marinovic B, et al. European consensus based (S2k) Guideline on the Management of Herpes Zoster guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV), Part 2:Treatment[J]. J Eur Acad Dermatol,2017,31(1):20-29. [7] 吴根鹏,朱为. 水痘-带状疱疹疫苗的使用现状及研究进展[J]. 中国生物制品学杂志,2016,29(3):323-328. [8] 李娟,李靖欣,金鹏飞,等. 带状疱疹疫苗临床研究进展[J].中华疾病控制杂志,2019,23(11):1409-1414. [9] 潘德全,王玮,付文锟,等. 基于立即早期蛋白IE62建立水痘—带状疱疹病毒感染性滴度检测方法[J]. 中国免疫学杂志,2018,34(12):1843-1848. [10] Dooling KL,Guo A,Patel M,et al. Recommendations of the advisory committee on immunization practices for use of herpes zoster vaccines [J]. Am J Transplant,2018,18(3):756-762. [11] Papagiannis D,Rachiotis G,Mariolis A,et al. Vaccination coverage of the elderly in Greece: a cross-sectional nationwide study[J]. Can J Infect Dis Med,2020(2020):5459793. [12] 仇静,孙晓冬,胡家瑜,等. 2020年5—6月上海市50岁成人带状疱疹疫苗接种意愿调查[J]. 中国疫苗和免疫,2021,27(3):307-310. [13] Lam AC, Chan MY, Chou HY, et al. A cross-sectional study of the knowledge, attitude, and practice of patients aged 50 years or above towards herpes zoster in an out-patient setting[J]. Hong Kong Med J,2017,23(4):365–373. [14] 周杰,汤喜红,赵家俊,等. 2014年上海市金山区60岁以上老年人肺炎疫苗接种意愿及影响因素分析[J]. 实用预防医学,2017,24(3):309-312. [15] 白云骅,马伟,吕敏,等. 北京市朝阳区 65岁以上老年人肺炎球菌疫苗接种意愿及影响因素[J]. 中国疫苗和免疫,2018,24(4):462-466. [16] 陆佳,梅克雯,王烨,等. 上海市闵行区60岁以上老年人对免费肺炎疫苗接种行为的认知和态度研究[J]. 复旦学报(医学版),2017,44(5):674-679. [17] 余蓉,马迪辉,刘亚东,等. 怀化市医疗机构工作人员新型冠状病毒疫苗接种意愿及影响因素[J]. 实用预防医学,2022,29(3):286-290. [18] Lu XY,Lu J,Zhang F,et al. Low willingness to vaccinate against herpes zoster in a Chinese metropolis[J]. Hum Vacc Immunother,2021,17(11):4163-4170.
2023, Vol. 30 
